“Provelmare will provide funding to Lyramid to execute on an agreed product development”
“A service agreement between Lyramid and Cellmid will be signed to provide continuity and ongoing support"
It seems that part of the agreement is that particular products will be developed and, at least within the immediate term, Cellmid will have some oversight of this development.
Given that neither Provemare, nor it's founder, come readily to mind when discussing international drug development it seems that Provemare might essentially see its role simply as an entrepreneurial funds provider/equity holder in the development of a potential future new drug company.
poorinvestor
- Forums
- ASX - By Stock
- AN1
- Ann: Agreement Signed for Sale of Lyramid Limited
Ann: Agreement Signed for Sale of Lyramid Limited, page-32
-
-
- There are more pages in this discussion • 302 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable